Autonomix Medical, Inc. (AMIX) - רווח נקי למניה (EPS TTM)

Initial trials of neurosensing systems for pain management are creating positive momentum for Autonomix Medical, Inc. (AMIX). However, pressure from major players in the monitoring niche is forcing the company to fight for a position in government procurement. The 12-month earnings per share history clearly demonstrates this process, where the -46.89 parameter determines the magnitude of the metric. Stability is maintained by a fabless production model and assembly at certified US plants.

For Autonomix Medical, Inc. (AMIX), the rolling earnings per share trend serves as an indicator of real business efficiency. The EPS TTM metric is calculated as the ratio of total annual net income to the number of securities. It neutralizes speculative noise, revealing the true yield of each asset. Amidst chip supply chain disruptions and sanction-related sales restrictions, this indicator becomes critical. A decline in this metric signals a risk of overpaying for the asset.